Cork Lower Harbour Energy Group demonstrated how a collaborative venture between four well-known companies in the pharma/medical devices sector (DePuy Synthes, GSK, Janssen Biologics and Novartis) can have widespread benefits.
The group built three 3MW wind turbines, reducing their sites’ electricity costs by 30% and used a community outreach team to assist with grant funding for sustainable initiatives. Through sharing resources, lessons learned and best practice, this collaborative effort has increased competiveness, increased energy efficiency, benefitting the local environment and local communities.
The project scope involved the planning, construction and commissioning of a 3-MW wind turbine on site with the generation of renewable energy to meet the entire site’s electrical load. The project originated as part of a larger project proposed by the Cork Lower Harbour Energy Group (CLHEG), of which Janssen Biologics is a key member. In early April 2014, the electrical load for the site was transferred to the newly operational wind turbine, which was under construction since September 2013. Not only is the site now powered by wind, but any excess electricity is sold and exported to the national power grid. This sustainable energy project allows for the generation of renewable electrical energy, reduced electrical energy costs by as much as 30 percent and CO2 emissions and improved competitiveness well into the future.
Why Wind Energy?